No.

Drug substance

Therapeutics

Tech. or Regulatory Status

1

Baloxavir Marboxil

Influenza virus infection

PV

2

Ruxolitinib phosphate

Myelofibrosis

PV

3

Lifitegrast

Xerophthalmia

Pilot

4

pyridostigmine Bromide

Myasthenia gravis

PV

5

Brivaracetam

Epilepsy

PV

6

Benidipine HCL

Hypertension, angina pectoris

NMPA submitted

7

Conivaptan HCL

Hyponatremia

NMPA submitted

8

Sugammadex sodium

Muscle relaxant antagonists

NMPA submitted

9

linezolid

Infection caused by specific strains

CXHL1300397

10

Polaprezinc

Gastric ulcer

国药准字H20120090

11

Clopidogrel sulfate

Platelet inhibitor

CYHS1201638

12

Cinepazide maleate

Acute ischemic stroke

CYHS1100004

13

Fasudil HCL

Vasospasm

CYHS1100006

14

Sulfobutylether-β-Cyclodextrin

Excipients

NMPA submitted